GH Research
Develops mebufotenin therapies and delivery systems for treatment-resistant depression.
$28.16
After-hours close+0.29 (+1.04%)
At close$27.87(−2.72%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 69.36%47.55M sharesInsiders 21.89%15.01M sharesOther 8.75%6.00M shares
Shares outstanding 68.56M · Float 50.88M · 74.2% free float
Institutions13F, as of Mar 31, 2026
55 holders · 47.55M shares · 12 new positions · 31 increased · 14 reduced · 10 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| LYNX1 Capital Management LP | 10.76M | 15.70% | +356.7K | May 4, 2026 |
| BVF Inc/IL | 8.65M | 12.62% | −177.6K | May 15, 2026 |
| Ra Capital Management, L.P. | 7.68M | 11.20% | 0 | May 15, 2026 |
| RTW Investments, LP | 5.93M | 8.66% | 0 | May 15, 2026 |
| FMR LLC | 5.14M | 7.49% | 0 | May 15, 2026 |
| Avoro Capital Advisors LLC | 1.80M | 2.63% | 0 | May 15, 2026 |
| Toronto Dominion Bank | 1.40M | 2.04% | +1.40Mnew | May 15, 2026 |
| Troluce Capital Advisors LLC | 990.5K | 1.44% | +617.3K | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Lynx1 Capital Management LP | 17.40% | 10.76M | 13G | May 18, 2026 ↗ |
| RA Capital Management, L.P. | 12.40% | 7.68M | 13G | Aug 14, 2025 ↗ |
| RTW Investments, LP | 8.90% | 5.50M | 13G | May 15, 2025 ↗ |
| FMR LLC | 8.20% | 5.09M | 13G | Aug 6, 2025 ↗ |
| Biotechnology Value Fund L P | 7.40% | 4.60M | 13G | May 15, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Florian Schonharting | director | 14.82M | 21.62% | Apr 1, 2026 |
| Magnus Clemensen Halle | officer: Managing Director, Ireland | 118.4K | 0.17% | Apr 2, 2026 |
| Michael Forer | director | 45.5K | 0.07% | Apr 2, 2026 |
| Duncan Moore | director | 14.6K | 0.02% | Apr 17, 2026 |
| Dermot John Hanley | director | 2.4K | 0.00% | Apr 2, 2026 |
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.